Nomura maintained a buy rating on Fortis Healthcare but raised the target to Rs 475 from Rs 388 earlier. There are adequate levers in place to deliver margin expansion. The global investment bank sees the hospital segment’s EBITDA margin to improve to 20.2% in FY25 from 16.9% in FY23.
Concurrent Gainers: 9 smallcap stocks gain for 5 days in a row
We identified 12 stocks that gained on all five days, delivering cumulative returns ranging from 10% to 30% during the period.
September 12, 2026